HP
Hikari Power’s Corvus Pharmaceuticals CRVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $200K | Hold |
49,959
| – | – | 0.02% | 61 |
|
2025
Q1 | $159K | Hold |
49,959
| – | – | 0.01% | 58 |
|
2024
Q4 | $267K | Hold |
49,959
| – | – | 0.02% | 57 |
|
2024
Q3 | $264K | Hold |
49,959
| – | – | 0.02% | 59 |
|
2024
Q2 | $91K | Hold |
49,959
| – | – | 0.01% | 61 |
|
2024
Q1 | $89K | Hold |
49,959
| – | – | 0.01% | 62 |
|
2023
Q4 | $88K | Hold |
49,959
| – | – | 0.01% | 62 |
|
2023
Q3 | $73K | Hold |
49,959
| – | – | 0.01% | 63 |
|
2023
Q2 | $114K | Hold |
49,959
| – | – | 0.01% | 62 |
|
2023
Q1 | $45K | Hold |
49,959
| – | – | ﹤0.01% | 65 |
|
2022
Q4 | $42K | Hold |
49,959
| – | – | ﹤0.01% | 65 |
|
2022
Q3 | $41K | Hold |
49,959
| – | – | ﹤0.01% | 66 |
|
2022
Q2 | $49K | Hold |
49,959
| – | – | 0.01% | 66 |
|
2022
Q1 | $82K | Buy |
49,959
+30,000
| +150% | +$49.2K | 0.01% | 67 |
|
2021
Q4 | $48K | Hold |
19,959
| – | – | ﹤0.01% | 66 |
|
2021
Q3 | $97K | Hold |
19,959
| – | – | 0.01% | 65 |
|
2021
Q2 | $53K | Hold |
19,959
| – | – | 0.01% | 69 |
|
2021
Q1 | $61K | Hold |
19,959
| – | – | 0.01% | 66 |
|
2020
Q4 | $71K | Hold |
19,959
| – | – | 0.01% | 69 |
|
2020
Q3 | $80K | Sell |
19,959
-41,000
| -67% | -$164K | 0.01% | 58 |
|
2020
Q2 | $166K | Hold |
60,959
| – | – | 0.02% | 59 |
|
2020
Q1 | $129K | Sell |
60,959
-19,041
| -24% | -$40.3K | 0.02% | 75 |
|
2019
Q4 | $435K | Sell |
80,000
-50,000
| -38% | -$272K | 0.05% | 68 |
|
2019
Q3 | $391K | Hold |
130,000
| – | – | 0.04% | 79 |
|
2019
Q2 | $486K | Hold |
130,000
| – | – | 0.05% | 74 |
|
2019
Q1 | $523K | Hold |
130,000
| – | – | 0.05% | 71 |
|
2018
Q4 | $477K | Buy |
130,000
+97,910
| +305% | +$359K | 0.05% | 72 |
|
2018
Q3 | $275K | Buy |
+32,090
| New | +$275K | 0.03% | 103 |
|